Why HIND? Vyome Holdings, Inc. Analysis, Price & AI Insights | Whystock
HIND
$2.09+0.08 (+4.24%)
Vyome Holdings, Inc., a clinical-stage specialty pharmaceutical company, develops therapeutic products targeting immuno-inflammatory and rare diseases in the United States.